Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

L Heidi Wagner


  • Director at Wave Life Sciences Ltd. (WVE), 2019-09-06
  • Svp, Global Government Affairs at Alexion Pharmaceuticals Inc (ALXN), 2018-03-01
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALXN $118.61 454 Officer 49,140 2018-02-28 Filing
ALXN $120.72 244 Officer 49,594 2018-02-27 Filing
ALXN $116.31 1,774 Officer 49,838 2018-02-08 Filing
ALXN $117.26 655 Officer 32,635 2018-02-05 Filing
ALXN $140.00 120 Officer 33,290 2017-10-02 Filing